Menu
Currency
GWAS Study

Genome-wide association study of bronchopulmonary dysplasia: a potential role for variants near the CRP gene.

Mahlman M, Karjalainen MK, Huusko JM et al.

28839172 PubMed ID
GWAS Study Type
1117 Participants
55 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

MM
Mahlman M
KM
Karjalainen MK
HJ
Huusko JM
AS
Andersson S
KM
Kari MA
TO
Tammela OKT
SU
Sankilampi U
LL
Lehtonen L
MR
Marttila RH
BD
Bassler D
PC
Poets CF
LT
Lacaze-Masmonteil T
DC
Danan C
DC
Delacourt C
PA
Palotie A
ML
Muglia LJ
LP
Lavoie PM
HA
Hadchouel A
RM
Rämet M
HM
Hallman M
Chapter II

Abstract

Summary of the research findings

Bronchopulmonary dysplasia (BPD), the main consequence of prematurity, has a significant heritability, but little is known about predisposing genes. The aim of this study was to identify gene loci predisposing infants to BPD. The initial genome-wide association study (GWAS) included 174 Finnish preterm infants of gestational age 24-30 weeks. Thereafter, the most promising single-nucleotide polymorphisms (SNPs) associated with BPD were genotyped in both Finnish (n = 555) and non-Finnish (n = 388) replication cohorts. Finally, plasma CRP levels from the first week of life and the risk of BPD were assessed. SNP rs11265269, flanking the CRP gene, showed the strongest signal in GWAS (odds ratio [OR] 3.2, p = 3.4 × 10-6). This association was nominally replicated in Finnish and French African populations. A number of other SNPs in the CRP region, including rs3093059, had nominal associations with BPD. During the first week of life the elevated plasma levels of CRP predicted the risk of BPD (OR 3.4, p = 2.9 × 10-4) and the SNP rs3093059 associated nominally with plasma CRP levels. Finally, SNP rs11265269 was identified as a risk factor of BPD (OR 1.8, p = 5.3 × 10-5), independently of the robust antenatal risk factors. As such, in BPD, a potential role for variants near CRP gene is proposed.

60 Finnish ancestry cases, 114 Finnish ancestry controls

Chapter III

Study Statistics

Key metrics and study information

1117
Total Participants
GWAS
Study Type
Yes
Replicated
234 European ancestry cases, 25 African ancestry cases, 633 European ancestry controls, 51 African ancestry controls
Replication Participants
European, African unspecified
Ancestry
Finland, France, Canada
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.